Why are not all paediatric cancer patients treated with protons? A population-based report from Sweden, 2016–2023
DOI:
https://doi.org/10.2340/1651-226X.2025.43726Keywords:
Radiotherapy, Pediatrics, Proton Therapy, Clinical Practice PatternAbstract
Background: In 2015, a proton therapy (PT) facility was established in Sweden with one aim being to ensure access for all children expected to benefit from PT. Despite potential dosimetric advantages and full subsidisation, PT is not always selected. This study explores reasons for choosing alternative radiotherapy (RT) modalities in a paediatric population.
Material and methods: RT courses delivered to patients ≤ 18 years during 2016–2023 were identified from a national registry. Medical records were retrospectively reviewed to identify reasons for not selecting PT.
Results: Only 34% (n = 275) of all courses identified were delivered with PT. Of the remaining 66% (n = 544), 90% were photon RT, 9% combined PT and photon RT, and 1% electron RT. Among photon RT courses, 97% were delivered with conventional external beam radiotherapy (EBRT), 2% with stereotactic radiotherapy (SRT), and 1% with brachytherapy. The most common reason for choosing photons was non-curative intent (35%), followed by equal or superior expected outcome compared to PT (23%), total body irradiation (TBI) (15%), and uncertainties due to air, organ motion, or metal in field (15%). Dosimetric comparison led to the selection of a favourable or equal photon plan in 8%. Logistical, social, and technical reasons constituted 4%.
Conclusion: While PT can reduce radiation exposure to healthy tissues, particularly important in children, clinical, logistical, and technical factors often necessitate alternative RT modalities. This study highlights the importance of individualised RT planning and multidisciplinary collaboration to balance medical, technical, and practical considerations to ensure optimal treatment approach in every child.
Downloads
References
Jairam V, Roberts KB, Yu JB. Historical trends in the use of radiation therapy for pediatric cancers: 1973–2008. Int J Radiat Oncol Biol Phys. 2013;85(3):e151–5.
https://doi.org/10.1016/j.ijrobp.2012.10.007 DOI: https://doi.org/10.1016/j.ijrobp.2012.10.007
Steinmeier T, Schulze Schleithoff S, Timmermann B. Evolving radiotherapy techniques in paediatric oncology. Clin Oncol (R Coll Radiol). 2019;31(3):142–50.
https://doi.org/10.1016/j.clon.2018.12.005 DOI: https://doi.org/10.1016/j.clon.2018.12.005
Tsang DS, Vargo JA, Goddard K, Breneman JC, Kalapurakal JA, Marcus KJ. Palliative radiation therapy for children with cancer. Pediatr Blood Cancer. 2021;68(Suppl 2):e28292.
https://doi.org/10.1002/pbc.28292 DOI: https://doi.org/10.1002/pbc.28292
Boterberg T, Dunlea C, Harrabi S, Janssens G, Laprie A, Whitfield G, et al. Contemporary paediatric radiation oncology. Arch Dis Child. 2023;108(5):332–7.
https://doi.org/10.1136/archdischild-2021-323059 DOI: https://doi.org/10.1136/archdischild-2021-323059
Årsrapport 2023 Svenska Barncancerregistret [Internet]. [cited 2024 Dec 11]. Available from: https://cceg.ki.se/documents/Arsrapport_SBCR_2023.pdf
Patyal B. Dosimetry aspects of proton therapy. Technol Cancer Res Treat. 2007;6(4 Suppl):17–23.
https://doi.org/10.1177/15330346070060S403 DOI: https://doi.org/10.1177/15330346070060S403
Greenberger BA, Yock TI. The role of proton therapy in pediatric malignancies: recent advances and future directions. Semin Oncol. 2020;47(1):8–22.
https://doi.org/10.1053/j.seminoncol.2020.02.002 DOI: https://doi.org/10.1053/j.seminoncol.2020.02.002
Ho ESQ, Barrett SA, Mullaney LM. A review of dosimetric and toxicity modeling of proton versus photon craniospinal irradiation for pediatrics medulloblastoma. Acta Oncol. 2017;56(8):1031–42.
https://doi.org/10.1080/0284186X.2017.1324207 DOI: https://doi.org/10.1080/0284186X.2017.1324207
Eaton BR, MacDonald SM, Yock TI, Tarbell NJ. Secondary malignancy risk following proton radiation therapy. Front Oncol. 2015;5:261.
https://doi.org/10.3389/fonc.2015.00261 DOI: https://doi.org/10.3389/fonc.2015.00261
Brandal P, Bergfeldt K, Aggerholm-Pedersen N, Backstrom G, Kerna I, Gubanski M, et al. A Nordic-Baltic perspective on indications for proton therapy with strategies for identification of proper patients. Acta Oncol. 2020;59(10):1157–63.
https://doi.org/10.1080/0284186X.2020.1817977 DOI: https://doi.org/10.1080/0284186X.2020.1817977
Kristensen I, Nilsson K, Nilsson P. Comparative proton and photon treatment planning in pediatric patients with various diagnoses. Int J Partic Ther. 2015;2(2):367–75.
https://doi.org/10.14338/IJPT-14-00026.1 DOI: https://doi.org/10.14338/IJPT-14-00026.1
Journy N, Indelicato DJ, Withrow DR, Akimoto T, Alapetite C, Araya M, et al. Patterns of proton therapy use in pediatric cancer management in 2016: an international survey. Radiother Oncol. 2019;132:155–61.
https://doi.org/10.1016/j.radonc.2018.10.022 DOI: https://doi.org/10.1016/j.radonc.2018.10.022
Martinsson U, Svard AM, Witt Nystrom P, Embring A, Asklid A, Agrup M, et al. Complications after proton radiotherapy in children, focusing on severe late complications. A complete Swedish cohort
2008–2019. Acta Oncol. 2023;62(10):1348–56.
https://doi.org/10.1080/0284186X.2023.2260946 DOI: https://doi.org/10.1080/0284186X.2023.2260946
Team RDC. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2024.
Wilkinson L. ggplot2: elegant graphics for data analysis by WICKHAM, H. Biometrics. 2011;67(2):678–9.
https://doi.org/10.1111/j.1541-0420.2011.01616.x DOI: https://doi.org/10.1111/j.1541-0420.2011.01616.x
Sjoberg DBM, Fruechtenicht C, Haesendonckx S, Treis T. ggsurvfit: flexible time-to-event figures. R package version 1.1.0. 2024. [Cited date: 2024 Dec 11] Available from: https://github.com/pharmaverse/ggsurvfit
Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P. International classification of childhood cancer, third edition. Cancer. 2005;103(7):1457–67.
https://doi.org/10.1002/cncr.20910 DOI: https://doi.org/10.1002/cncr.20910
Glimelius B, Ask A, Bjelkengren G, Bjork-Eriksson T, Blomquist E, Johansson B, et al. Number of patients potentially eligible for proton therapy. Acta Oncol. 2005;44(8):836–49.
https://doi.org/10.1080/02841860500361049 DOI: https://doi.org/10.1080/02841860500361049
Salins N, Hughes S, Preston N. Palliative care in paediatric oncology: an update. Curr Oncol Rep. 2022;24(2):175–86.
https://doi.org/10.1007/s11912-021-01170-3 DOI: https://doi.org/10.1007/s11912-021-01170-3
Kutzko JH, Dadwal P, Holt T, Rahman MA, Zahir SF, Hickey B. Defining the expected 30-day mortality for patients undergoing palliative radiotherapy: a meta-analysis. Radiother Oncol. 2022;168:147–210.
https://doi.org/10.1016/j.radonc.2022.01.030 DOI: https://doi.org/10.1016/j.radonc.2022.01.030
Thomas H, Timmermann B. Paediatric proton therapy. Br J Radiol. 2020;93(1107):20190601.
https://doi.org/10.1259/bjr.20190601 DOI: https://doi.org/10.1259/bjr.20190601
Hoeben BAW, Pazos M, Seravalli E, Bosman ME, Losert C, Albert MH, et al. ESTRO ACROP and SIOPE recommendations for myeloablative total body irradiation in children. Radiother Oncol. 2022;173:119–33.
https://doi.org/10.1016/j.radonc.2022.05.027 DOI: https://doi.org/10.1016/j.radonc.2022.05.027
Milgrom SA, Dandapani SV, Wong J, Kalapurakal J, Smith KS, Han C, et al. Incorporating intensity modulated total body irradiation into a Children’s Oncology Group trial: rationale, techniques, and safeguards. Pediatr Blood Cancer. 2024;71(11):e31185.
https://doi.org/10.1002/pbc.31185 DOI: https://doi.org/10.1002/pbc.31185
Mirandola A, Colombo F, Cavagnetto F, Cavallo A, Gusinu M, Molinelli S, et al. Dosimetric comparison between proton and photon radiation therapies for pediatric neuroblastoma. Int J Part Ther. 2024;12:100100.
https://doi.org/10.1016/j.ijpt.2024.100100 DOI: https://doi.org/10.1016/j.ijpt.2024.100100
Cunningham DA, Breen WG, Johnson JE, Mullikin TC, Bradley TB, Sorenson KL, et al. Proton whole-lung irradiation: initial report of outcomes. Int J Radiat Oncol Biol Phys. 2023;115(4):866–72.
https://doi.org/10.1016/j.ijrobp.2022.10.001 DOI: https://doi.org/10.1016/j.ijrobp.2022.10.001
Embring A, Kristensen I, Nilsson MP, Engellau J, Blomstrand M, Frojd C, et al. Comparative proton and photon treatment plans in children treated for neuroblastoma. Acta Oncol. 2025;64:939–45.
https://doi.org/10.2340/1651-226X.2025.43865 DOI: https://doi.org/10.2340/1651-226X.2025.43865
Kiss-Miki R, Obeidat M, Mate V, Teutsch B, Agocs G, Kiss-Dala S, et al. Proton or photon? Comparison of survival and toxicity of two radiotherapy modalities among pediatric brain cancer patients: a systematic review and meta-analysis. PLoS One. 2025;20(2):e0318194.
https://doi.org/10.1371/journal.pone.0318194 DOI: https://doi.org/10.1371/journal.pone.0318194
Miao Y, Wu D, Li Y, Ji Y, Sang Y. Radiation therapy for childhood-onset craniopharyngioma: systematic review and meta-analysis. J Neurooncol. 2025;172(1):89–98.
https://doi.org/10.1007/s11060-024-04914-w DOI: https://doi.org/10.1007/s11060-024-04914-w
Pakela JM, Knopf A, Dong L, Rucinski A, Zou W. Management of motion and anatomical variations in charged particle therapy: past, present, and into the future. Front Oncol. 2022;12:806153.
https://doi.org/10.3389/fonc.2022.806153 DOI: https://doi.org/10.3389/fonc.2022.806153
Ritchie T, Awrey S, Maganti M, Chahin R, Velec M, Hodgson DC, et al. Paediatric radiation therapy without anaesthesia – are the children moving? Radiother Oncol. 2024;193:110120.
https://doi.org/10.1016/j.radonc.2024.110120 DOI: https://doi.org/10.1016/j.radonc.2024.110120
Vogel J, Grewal A, O’Reilly S, Lustig R, Kurtz G, Minturn JE, et al. Risk of brainstem necrosis in pediatric patients with central nervous system malignancies after pencil beam scanning proton therapy. Acta Oncol. 2019;58(12):1752–56.
https://doi.org/10.1080/0284186X.2019.1659996 DOI: https://doi.org/10.1080/0284186X.2019.1659996
Andratschke N, Willmann J, Appelt AL, Alyamani N, Balermpas P, Baumert BG, et al. European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making. Lancet Oncol. 2022;23(10):e469–78.
https://doi.org/10.1016/S1470-2045(22)00447-8 DOI: https://doi.org/10.1016/S1470-2045(22)00447-8
Mohan R, Peeler CR, Guan F, Bronk L, Cao W, Grosshans DR. Radiobiological issues in proton therapy. Acta Oncol. 2017;56(11):1367–3.
https://doi.org/10.1080/0284186X.2017.1348621 DOI: https://doi.org/10.1080/0284186X.2017.1348621
Toma-Dasu I, Dasu A, Vestergaard A, Witt Nystrom P, Nystrom H. RBE for proton radiation therapy – a Nordic view in the international perspective. Acta Oncol. 2020;59(10):1151–6.
https://doi.org/10.1080/0284186X.2020.1826573 DOI: https://doi.org/10.1080/0284186X.2020.1826573
Dalmasso C, Alapetite C, Bolle S, Goudjil F, Lusque A, Desrousseaux J, et al. Brainstem toxicity after proton or photon therapy in children and young adults with localized intracranial ependymoma: a French retrospective study. Radiother Oncol. 2024;194:110157.
https://doi.org/10.1016/j.radonc.2024.110157 DOI: https://doi.org/10.1016/j.radonc.2024.110157
Indelicato DJ. No question: proton therapy is safe. Neuro Oncol. 2022;24(9):1582–3.
https://doi.org/10.1093/neuonc/noac121 DOI: https://doi.org/10.1093/neuonc/noac121
Indelicato DJ, Ioakeim-Ioannidou M, Bradley JA, Mailhot-Vega RB, Morris CG, Tarbell NJ, et al. Proton therapy for pediatric ependymoma: mature results from a bicentric study. Int J Radiat Oncol Biol Phys. 2021;110(3):815–20.
https://doi.org/10.1016/j.ijrobp.2021.01.027 DOI: https://doi.org/10.1016/j.ijrobp.2021.01.027
Davila Fajardo R, Scarzello G, Gaze MN, Boterberg T, Cameron A, Fuchs J, et al. Brachytherapy for rhabdomyosarcoma: survey of international clinical practice and development of guidelines. Radiother Oncol. 2024;195:110273.
https://doi.org/10.1016/j.radonc.2024.110273 DOI: https://doi.org/10.1016/j.radonc.2024.110273
Stenman J, Wickart-Johansson G, Sundquist F, Nilsson J, Ljungman G, Osterlundh G, et al. Five-year follow-up after multimodal treatment incorporating HDR brachytherapy for bladder prostate rhabdomyosarcoma in children. Int J Radiat Oncol Biol Phys. 2022;113(2):355–9. DOI: https://doi.org/10.1016/j.ijrobp.2022.01.034
Karlsson M, Bjork-Eriksson T, Mattsson O, Mattsson S, Montelius A, Nilsson P, et al. “Distributed proton radiation therapy” – a new concept for advanced competence support. Acta Oncol. 2006;45(8):
1094–101.
https://doi.org/10.1080/02841860600897876 DOI: https://doi.org/10.1080/02841860600897876
Additional Files
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2025 Anna Asklid, Ingrid Kristensen, Ulla Martinsson, Martin P. Nilsson, Malin Blomstrand, Måns Agrup, Anna Flejmer, Anna-Maja Svärd, Charlotta Fröjd, Erik Almhagen, Jacob Engellau, Anna Embring
This work is licensed under a Creative Commons Attribution 4.0 International License.
